These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33639900)

  • 1. Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia.
    Lan Y; Liu F; Chang L; Liu L; Zhang Y; Yi M; Cai Y; Feng J; Han Z; Han Z; Zhu X
    BMC Pediatr; 2021 Feb; 21(1):102. PubMed ID: 33639900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia: A Retrospective Controlled Study.
    Sheng XF; Li H; Hong LL; Zhuang H
    Turk J Haematol; 2022 Jun; 39(2):117-129. PubMed ID: 35448935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study.
    Luo X; Lu H; Xiu B; Wu H; Li B; Li P; Chen Y; Zhou L; Zhang W; Dong Y; Liang A; Ding Y
    Exp Ther Med; 2018 Feb; 15(2):1966-1974. PubMed ID: 29434791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu
    Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Mao N; Guo ZK; Ning HM; Wang HX; Zhu H
    Stem Cells Transl Med; 2021 Feb; 10(2):291-302. PubMed ID: 32978903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcomes of 125 children with aplastic anemia].
    Luo CJ; Chen J; Xue HL; Tang JY; Pan C; Jiang H; Dong L; Luo CY; Ye QD; Zhou M; Gu LJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):531-5. PubMed ID: 21122332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased immunosuppressive treatment combined with unrelated umbilical cord blood infusion in children with severe aplastic anemia.
    Xie LN; Fang Y; Yu Z; Song NX; Kong FS; Liu XM; Zhou F
    Cell Immunol; 2014; 289(1-2):150-4. PubMed ID: 24838091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia.
    Yuan F; Li M; Wei X; Fu Y
    Pediatr Hematol Oncol; 2024 Aug; 41(5):322-335. PubMed ID: 38436082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modulation of umbilical cord blood mesenchymal stem cells on Treg cells in the patients with aplastic anemia].
    Cao YN; Zhou F; Song NX; Fang Y; Guan R
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2678-2681. PubMed ID: 28910956
    [No Abstract]   [Full Text] [Related]  

  • 14. Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy.
    He C; Yang C; Zeng Q; Liu Z; Wang F; Chen Q; Liu T
    Stem Cell Res Ther; 2023 Aug; 14(1):224. PubMed ID: 37649079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of rabbit antithymocyte globulin plus cyclosporin A as first-line immunosuppressive therapy for the childhood with severe aplastic anemia.].
    Liu LY; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):749-53. PubMed ID: 20137310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.
    Li X; Shangguan X; Wang H; Wang Q; Zhang Y; Han B; Liu R; Zhang F; Fu R; Lin Z; Miao M; Ma X; Lei M; Wu D; Liu L
    Ann Hematol; 2024 Sep; 103(9):3483-3491. PubMed ID: 39088061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
    Zheng Y; Liu Y; Chu Y
    Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia.
    Clé DV; Santana-Lemos B; Tellechea MF; Prata KL; Orellana MD; Covas DT; Calado RT
    Cytotherapy; 2015 Dec; 17(12):1696-705. PubMed ID: 26589752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
    Scheinberg P; Wu CO; Nunez O; Young NS
    J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.